NCT02832999View on ClinicalTrials.gov

Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

sub cutaneous liraglutide

Liraglutide 1.2mg/day

DRUG

Oral Vildagliptin

Vildagliptin 50mg/day

Trial Locations (1)

Unknown

National Obesity Centre, Yaoundé

All Listed Sponsors
collaborator

University of Yaounde 1

OTHER

collaborator

University of Buea

OTHER

lead

Yaounde Central Hospital

OTHER_GOV

NCT02832999 - Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes | Biotech Hunter | Biotech Hunter